Reaching New Heights Together

Dear colleagues,

As we move into a new fiscal year, I want to take a moment to reflect on what we've achieved together and where we are headed.

Q3 was a strong quarter for Pharma Systems, with 4.8% growth driven by outstanding performance in ADDS and Services, and remarkable delivery in biologics and GLP-1 where our plants supplied 70 million more units than planned. These results are a testament to your hard work, resilience, and collaboration across every function.

But our journey doesn't stop here. This is the time when every product counts — when focus, discipline, and execution will make the difference between finishing the year well and finishing it strong. We know the environment is challenging: the vaccine market is shifting, and competition remains intense. That's why it's more important than ever that we bring our best to every customer, every order, and every interaction.

At the same time, we're laying important foundations for the future. The Customer Engagement Model launching later this year will simplify how we respond to customers and strengthen accountability. The FutureUp! Culture Journey continues to embed our four cultural pillars into daily work, helping us act as one team and learn every day. And with the Pharma Knowledge Training rolling out, associates across the globe will be better equipped to understand our customers' world and speak their language.

These efforts are not side projects — they are part of how we transform ourselves to lead the market and deliver lasting impact.

Thank you for everything you've done to bring us this far. As we move into FY26 let's build on our achievements and keep working together to become the undisputed market leader—driven by our culture, our customer focus, and our commitment to innovation. The journey continues, and I'm confident that with our teamwork and discipline, we'll reach new heights together.

Warm regards,

Patrick Jeukenne

Worldwide President of Pharma Systems

Strategy Update

Pharma Systems Charts Bold Path Forward at Global Town Hall

More than 1,000 associates joined the Global Pharma Systems Town Hall for key updates on business performance, leadership transitions, and the transformation of how Pharma Systems connects with customers, builds culture, and deepens industry expertise. With strong Q3 results as the backdrop, Patrick Jeukenne, Worldwide President, highlighted the progress made—and the momentum still to build.

BD Featured in Industry Report: Powering the Future of Injectable Drug Delivery

BD is featured in a new Drug Development & Delivery industry report that spotlights how device makers are driving the transition from intravenous (IV) to subcutaneous (SC) drug delivery. The report highlights BD's leadership in tackling one of the most pressing challenges in injectable delivery: enabling high-dose biologics to be administered safely and efficiently outside traditional infusion settings.

Innovation and Products News

Boan Biotech Wins Approval for China's First Dulaglutide Biosimilar, Powered by BD Delivery Systems

In a landmark development for diabetes care and biosimilar innovation, Boan Biotech has received regulatory approval from China's National Medical Products Administration (NMPA) to launch its dulaglutide biosimilar, BA5101. The approval is a major win for BD's integrated system—Hypak® for Biotech and Physioject®—which will be used to deliver Boan's once-weekly injectable treatment for adults with type 2 diabetes.

Healthcare Packaging Spotlight: BD and ten23 health Partner to Combat Counterfeiting with RFID Traceability

As highlighted in a recent Healthcare Packaging, the global healthcare industry is grappling with a growing threat: counterfeit drugs and medical devices. One innovative response comes from Pharma Systems and Swiss-based CDMO ten23 health, who have joined forces to pilot an RFID-enabled system designed to secure injectable therapies from production to patient.

Customer Success Stories

BD Secures Emcure Deal, Expands Pen Injector Footprint in India

BD has clinched a major win in India's growing injectable drug delivery market, signing Emcure Pharmaceuticals as a first-time customer for its Vystra™ pen injector platform. The deal covers eight configurations of Semaglutide, a GLP-1 therapy, and underscores BD's ability to combine speed with technical depth in a competitive landscape.

Turning Risk into Resilience: BD and Koçak's Strategic Win in Turkey's Antico Market

In a market rocked by inflation and aggressive pricing, BD and its key partner Koçak faced a pivotal moment in Turkey's Antico space. With $2.3M in projected revenue at risk and FY25 orders uncertain, BD mobilized a cross-functional team to craft a milestone-based discount model that gave Koçak control and confidence in a volatile environment. Discover how this bold, collaborative approach turned risk into resilience—and secured growth.

Operational Excellence

Pharma Systems Launches New Customer Engagement Model to Accelerate Service and Restore Trust

Pharma Systems is transforming how it supports clients—faster responses, clearer roles, and empowered teams. Built on customer and associate feedback, this new model sets bold standards for service and transparency. See how it's reshaping engagement across the organization.

PEGA Launch Streamlines Change Control Across Pharma Systems

Pharma Systems has rolled out PEGA, a digital platform designed to simplify and accelerate change control processes across its global network.

The launch marks the culmination of a nine-month effort involving more than 300 project days.

Olympus Project Puts Pharma Systems R&D on a Common Climb

BD's Global Services team in Pharma Systems has taken a decisive step in shaping the future of research and development with the launch of the Olympus Project—an initiative to unify its global mission, vision and operating principles.

People & Culture

FutureUp! Culture Journey: Bringing Our Pillars to Life, One Activation at a Time

Pharma Systems is on an exciting journey to strengthen its culture and leadership behaviors through the FutureUp! Culture Journey. After months of listening sessions and the official launch in May, the focus has now shifted to activation—turning ideas into action and values into everyday behaviors.

Pharma Systems Launches Comprehensive Training to Boost Industry Knowledge and Customer Focus

Pharma Systems has launched a global Pharma Knowledge Training program to boost industry expertise and enhance customer relationships. The initiative, unveiled at the recent Global Pharma Systems Town Hall, is designed to equip associates with a foundational understanding of the pharmaceutical landscape—an essential step for a B2B organization committed to customer-centricity and innovation.

Watch the introduction from Patrick Jeukenne

READ MORE